DeepMed Research

Universities of Cologne

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Private

Established: 1388-01-01

Employees: 251

Market Cap: -

Website: http://www.portal.uni-koeln.de/uoc_home.html?l=1

Clinical Trials

Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges

Not Applicable

Recruiting

Conditions: Hyponatremia

Interventions: Other: Water administration
Other: NaCl-Administration

First Posted Date: 2024-05-09

Last Posted Date: 2024-05-09

Lead Sponsor: University of Cologne

Target Recruit Count: 60

Registration Number: NCT06408077

Locations: 🇩🇪
Department II of Internal Medicine,University of Cologne, Cologne, Germany

Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma

Phase 2

Not yet recruiting

Conditions: Hodgkin Lymphoma

Interventions: Drug: Pembrolizumab

First Posted Date: 2023-09-21

Last Posted Date: 2025-04-06

Lead Sponsor: University of Cologne

Target Recruit Count: 40

Registration Number: NCT06045195

Locations: 🇩🇪
1st Department of Medicine, Cologne University Hospital, Cologne, Germany

Continuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm Infants

Not Applicable

Recruiting

Conditions: Mother-Infant Interaction
Infant Development
Preterm Birth

Interventions: Procedure: skin-to-skin contact

First Posted Date: 2023-08-03

Last Posted Date: 2023-08-07

Lead Sponsor: University of Cologne

Target Recruit Count: 60

Registration Number: NCT05975203

Locations: 🇩🇪
University hospital of Cologne, Department of Neonatology, Cologne, Northrhine-westfalia, Germany

Hair Cortisol as Marker of Chronic Stress in Preterm and Term Fathers - Fathair-study

Recruiting

Conditions: Father-Child Relations
Stress, Psychological
Premature Birth

Interventions: Diagnostic Test: measurement of cortisol level

First Posted Date: 2023-08-01

Last Posted Date: 2024-11-27

Lead Sponsor: University of Cologne

Target Recruit Count: 120

Registration Number: NCT05969431

Locations: 🇩🇪
University Hospital of Cologne, Cologne, Northrhine-westfalia, Germany

Platelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura

Recruiting

Conditions: Acquired Thrombotic Thrombocytopenic Purpura

Interventions: Drug: Cablivi

First Posted Date: 2023-05-25

Last Posted Date: 2024-12-05

Lead Sponsor: University of Cologne

Target Recruit Count: 160

Registration Number: NCT05876221

Locations: 🇩🇪
University Hospital of Cologne, Cologne, Germany

Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)

Not Applicable

Active, not recruiting

Conditions: Non-small Cell Lung Cancer Stage IV

Interventions: Other: DigiNet intervention

First Posted Date: 2023-04-18

Last Posted Date: 2024-06-04

Lead Sponsor: University of Cologne

Target Recruit Count: 850

Registration Number: NCT05818449

Locations: 🇩🇪
Klinikum Leverkusen, Leverkusen, NRW, Germany
🇩🇪
Universitätsklinikum Würzburg, Würzburg, Bayern, Germany
🇩🇪
Universitätsklinikum Aachen, Aachen, NRW, Germany

and more 38 locations

Dietary Interventions During Living Kidney Donations

Not Applicable

Recruiting

Conditions: Living-Kidney Donors

Interventions: Dietary Supplement: Fasting mimicking diet
Dietary Supplement: Ketogenic diet
Dietary Supplement: Dietary restriction of sulfur containing amino acids
Dietary Supplement: Control Group ( healthy, low-fat, moderate protein and high carbohydrate diet)

First Posted Date: 2023-02-02

Last Posted Date: 2024-12-11

Lead Sponsor: University of Cologne

Target Recruit Count: 80

Registration Number: NCT05709600

Locations: 🇩🇪
Department II of Internal Medicine, Center for Molecular Medicine Cologne (CMMC), University Hospital of Cologne, Cologne, Germany

Evaluation of Volume and Electrolyte Balance in Hyponatremia Treatment - a Prospective Observational Trial

Recruiting

Conditions: Non-hypervolemic Hyponatremia

Interventions: Other: Patients

First Posted Date: 2023-01-20

Last Posted Date: 2024-12-09

Lead Sponsor: University of Cologne

Target Recruit Count: 50

Registration Number: NCT05692726

Locations: 🇩🇪
University Hospital of Cologne, Cologne, Germany

Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL

Phase 2

Recruiting

Conditions: Non-Hodgkin Lymphoma

Interventions: Drug: Tafasitamab
Drug: Lenalidomide
Drug: Rituximab
Drug: Methotrexate

First Posted Date: 2022-10-17

Last Posted Date: 2025-04-06

Lead Sponsor: University of Cologne

Target Recruit Count: 20

Registration Number: NCT05583071

Locations: 🇩🇪
Universitätsklinikum Freiburg, Freiburg, Baden-Würtemberg, Germany
🇩🇪
Klinikum Stuttgart - Katharienenhospital, Stuttgart, Baden-Württemberg, Germany
🇩🇪
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Hamurg, Germany

and more 3 locations

Spine Registry University Hospital of Cologne- Department of Orthopedics

Completed

Conditions: Outcome, Fatal
Spondylodiscitis
Vertebral Osteomyelitis

First Posted Date: 2022-08-03

Last Posted Date: 2022-08-03

Lead Sponsor: University of Cologne

Target Recruit Count: 355

Registration Number: NCT05486494

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy